Today's episode features Ryan Zurrer, founder of Vine Ventures, one of the first venture capital funds investing in psychedelic medicine. Ryan has deep roots in psychedelics culture and understands the many cultures within the psychedelic space. His fund is aligned with those values.

If you’re a founder, investor, or early hire at a psychedelic company, this episode is a must-listen!

In this episode, we discuss:

Which psychedelic business models are a good fit for venture capital?
Why did Ryan start Vine Ventures?
What traits of entrepreneurs does Ryan invest in?
Which form of psychedelic medicine is better: natural or synthetic compounds?

Links to topics discussed in this episode:

Pharmauasca
Oregon Initiative Measure 109
ENTHEON
PsyGen
California Sober
Atai
Compass
Get in touch with Ryan Zurrer - TW: @rzurrer LI: Ryan Zurrer

Read the transcript here.

Watch episode 3 on YouTube.

Created by Greg Kubin and Matias Serebrinsky
Host: Greg Kubin
Produced by Jonathan A. Davis

Find us at businesstrip.fm
Follow us on Instagram and Twitter!

Theme music by Dorian Love
Additional music by Blue Dot Sessions and Chad Crouch

How to invest in psychedelic companies: Vine Ventures' Founder Ryan Zurrer